Skip to main content
    I

    ImageneBio, Inc. (IMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.90
    +0.70 (+21.88%)

    Market Cap: $39.86M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    ImageneBio, Inc. (IMA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    ImageneBio (IMA) has a market cap of $39.86M. It kept -5700.13% of revenue as net income over the last 12 months. Its share count is up 94.64% from a year earlier.

    Total Valuation

    Market Cap$39.86M
    Latest price (Nov 17, 2026)$3.90

    Key Dates

    The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 1, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    Shares Outstanding17.12M
    Shares Change (YoY)+94.64%

    Valuation Ratios

    Sales and book value multiples are 83.5x and 0.5x. Its year-end P/S ranged from 74.0x to 479.7x from 2021 to 2024.

    P/S Ratio83.5x
    P/B Ratio0.5x

    Valuation history and multiples

    Price Statistics

    The stock is down 52.24% over 52 weeks and trades 9.93% below its 50-day average.

    Beta (1Y)0.64
    52-Week Change-52.24%
    1-Month Change-2.50%
    3-Month Change-31.46%
    6-Month Change-25.71%
    5-Year Change-96.82%
    Total Return (1Y)-52.24%
    Total Return (3Y CAGR)-43.47%
    Total Return (5Y CAGR)-54.21%
    Return vs SPY (1Y)-60.45%
    Max Drawdown (1Y)-58.44%
    Max Drawdown (3Y)-88.20%
    Sharpe Ratio (1Y)-1.12
    Correlation with SPY (1Y)0.15
    50-Day Average$4.33
    200-Day Average$5.44
    52-Week Range$3.13 to $7.89
    RSI (14 Days)47.4
    Average Volume (20 Days)15.04K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 16.17x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio16.17x
    Quick Ratio16.17x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -35.59% and return on assets is -31.99% over the last 12 months.

    Return on Equity (ROE)-35.59%
    Return on Assets (ROA)-31.99%
    ROA (5Y Average)-69.70%
    ROIC (5Y Average)-35.58%
    Asset Turnover0.01x

    Scores

    IMA has an Altman Z-Score of 0.07, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score0.07
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $800.00K over the last 12 months matched the 12 months before.

    Revenue$800.00K
    Revenue Growth (YoY)0.00%
    Gross Profit$800.00K
    Operating Income-$43.48M
    Pretax Income-$45.87M
    Net Income-$45.60M
    Reported EPS (TTM)-$3.11

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 89.90% of the $142.54M in total assets.

    Cash and Equivalents$84.85M
    Total Debt$0
    Net Cash$84.85M
    Net Cash Per Share$4.96
    Working Capital$122.52M
    Shareholder Equity$128.14M
    Book Value Per Share$7.48
    Total Assets$142.54M
    Total Liabilities$14.40M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$40.61M
    FCF Per Share-$3.57
    Depreciation and Amortization$1.04M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -5435.63%.

    Gross Margin100.00%
    Operating Margin-5435.63%
    Pretax Margin-5734.25%
    Net Margin-5700.13%

    Growth

    Revenue fell 62.86% a year over 3 years.

    Revenue Growth (3Y CAGR)-62.86%
    Revenue Growth (5Y CAGR)-38.64%

    Revenue and profit by year

    Dividends and Yields

    IMA does not pay a dividend.

    Buyback Yield0.04%
    Shareholder Yield0.04%

    Stock Splits

    The last split was a 1-for-12 reverse split on Jul 28, 2025.

    Last Split DateJul 28, 2025
    Split TypeReverse split
    Split Ratio1:12

    Peer Position

    Against 4 similar companies, IMA has the 3rd highest P/S.

    P/S Ratio83.5x vs 124.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)0.00% vs -100.00% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IMA

    What is IMA's market cap?

    ImageneBio has a market cap of $39.86M.

    How many shares of IMA are outstanding?

    ImageneBio has 17.12M shares outstanding. The count is up 94.64% from a year earlier.

    Does IMA pay a dividend?

    No. ImageneBio does not pay a dividend.

    How much debt does IMA have?

    ImageneBio has $0 of total debt and $84.85M of cash and equivalents, a net cash position of $84.85M.